01 mar: Sjælsø Gruppen A/S' årsregnskabsmeddelelse for 2010
01 mar: FormueEvolution I A/S - Insiderer handel
01-03-2011 09:00:00

Cerner Fulfills CE Marking Requirements for Medical Device Connectivity Solution

Cerner CareAware iBus Solution Approved to be Offered in the European Union

KANSAS CITY, Mo., 2011-03-01 09:00 CET (GLOBE NEWSWIRE) --Cerner Corporation today announced that the CareAware iBus has received CE

Marking certification from BSI on the basis of examination under Council

Directive 93/42/EEC Annex II Section 3.2.

The Cerner CareAware iBus solution connects important medical device

information about patient health from disparate systems to the patient's

electronic health record (EHR). This solution will be immediately available to

healthcare organizations in the EU allowing them to access medical information

from medical devices and EHRs to make informed care decisions.

"As a global leader in the development of device connectivity and workflow

solutions, we are excited to extend the offering of our CareAware iBus solution

into the European market," said Tom Herzog, Cerner vice president for IT and

healthcare devices. "Connecting medical devices to the patient's EHR supports

healthcare interoperability, enabling patients and caregivers to access the

right information at the right time."

The Cerner CareAware iBus solution works to improve clinician workflow and

patient safety by:

-- Reducing time spent manually transcribing device data into the EHR,

allowing clinicians to spend more time on direct patient care;

-- Decreasing the chance of medication errors by virtually eliminating manual

data entry errors and increasing the accuracy of data;

-- Providing the ability to automatically perform calculations on medical

device data, including trending capabilities for various sources of

information like heart rate and blood pressure;

-- Reducing interface implementation and maintenance costs through efficient

management of medical device deployment; and

-- Improving monitoring abilities of device performance, connectivity status

and device utilization.

The Cerner CareAware iBus solution provides additional functionality and

workflow benefits. Plug-and-play capabilities for connecting medical devices to

any EHR system allow medical devices to connect to the Cerner CareAware iBus

much like a USB port that quickly and easily connects peripheral devices to a

computer. Once a device is connected, it is immediately recognized and can

begin transmitting patient data to the EHR. The solution also allows waveform

data to be transmitted directly into the EHR. Clinicians may then analyze the

patient's device data in the context of other clinically relevant data for a

specific time period, enabling them to make the best informed care decisions

with all relevant information easily accessible from multiple medical devices.

About Cerner

Cerner is transforming healthcare by eliminating error, variance and waste for

healthcare providers and consumers around the world. Cerner® solutions optimize

processes for healthcare organizations ranging in size from single-doctor

practices, to health systems, to entire countries, for the pharmaceutical and

medical device industries, employer health and wellness services industry and

for the healthcare commerce system. These solutions are licensed by

approximately 9,000 facilities around the world, including more than 2,600

hospitals; 3,500 physician practices covering more than 30,000 physicians; 500

ambulatory facilities, such as laboratories, ambulatory centers, cardiac

facilities, radiology clinics and surgery centers; 800 home health facilities;

and 1,600 retail pharmacies. The trademarks, service marks and logos

(collectively, the "Marks") set forth herein are owned by Cerner Corporation

and/or its subsidiaries in the United States and certain other countries

throughout the world. Nasdaq:CERN. For more information about Cerner, please

visit www.cerner.com, Twitter, Facebook, and YouTube .

CONTACT: Cerner Media Contact:

Kelly Johnson

+1-816-777-8466

kelly.johnson@cerner.com

Cerner Investors Contact:

Allan Kells

+1-816-201-2445

akells@cerner.com

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
26 jan
PNDORA
At forstå Pandora er ikke bare at elske eller hade charms og evt. kalde selskabets smykker for "blik..
39
24 jan
VWS
  På den lille ø Rügen ud for Stralsund i Tyskland var der under 2. verdenskrig en del af Hitlers vå..
25
21 jan
 
Jeg har startet nedenstående debat: http://www.proinvestor.com/index.php?p=debat_1&postid=71068   Ha..
23
24 jan
VWS
Jeg kan da ikke tale en skid op. Men jeg kan dele et overblik over selskabet som andre ikke har. Men..
19
21 jan
GEN
I anledning af at Genmab er gået over 400 har jeg lavet et indlæg om forskellige forhold der kan dri..
18
25 jan
TORM
Torm havde væsentligt flere skibe i 2008 end de har nu, så jeg tror ikke du skal være så ked af, at ..
17
24 jan
VWS
I stedet for at bruge så mange kræfter på mig syntes jeg at du skulle bruge dem på at lave de kritis..
15
21 jan
ATLA-DKK
Man skal ikke kaste med sten når man selv bor i glashus - tror du ved hvad jeg mener.   Og dit skriv..
15
25 jan
 
Hej folkens   I forbindelse med at jeg sidder og udbygger og (forhåbentligt) forbedrer på regnearket..
14
22 jan
E:ARCHER
Det var fandme da et flabet svar!   Hvad er du ikke fatter Goodwrench ? læs for helvede indlægget, s..
14

Novo Nordisk får amerikansk godkendelse Norditropin

27-01-2015 06:45:50
Det danske medicinalselskab Novo Nordisk har fået de amerikanske sundhedsmyndigheder godkendelse af væksthormonet Norditropin Flexpro med den høje dosis 30 mg/3..

Novo/ABM: Løfter kursmål med 13 pct. inden regnskab - NY

26-01-2015 14:25:37
Alm. Brand Markets ser frem mod årsregnskabet fra medicinalselskabet Novo Nordisk med positive forventninger og løfter sit kursmål for aktien til 340 kr. fra ti..

Aktier/middag: C20 genfinder rekordrytmen med Vestas i spidsen

26-01-2015 11:29:30
Vestas og resten af de danske eliteaktier har vendt morgentimernes nedadvendte mundvige opad og lagt sig tilbage på rekordkurs.C20 Cap-indekset ligger sidst på ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo/ABM: Løfter kursmål med 13 pct. inden regnskab - NY
2
Asger Aamund sælger sin andel af Bavarian Nordic - NY
3
Aktier/middag: C20 genfinder rekordrytmen med Vestas i spidsen
4
Novo Nordisk får amerikansk godkendelse Norditropin
5
OPTAKT Novo Q4 30/1: Pipeline-data overskygger regnskabstal

Copyright Euroinvestor A/S 2015  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
27. januar 2015 11:23:13
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20150121.1 - EUROWEB2 - 2015-01-27 11:23:13 - 2015-01-27 11:23:13 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x